By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CeraPedics, Inc. 

11025 Dover Street
Suite 1600
Westminster  Colorado  80021  U.S.A.
Phone: 303-974-6275 Fax: 303-974-6285


Medical Device

Company News
CeraPedics, Inc. Files Premarket Approval Application With FDA For i-FACTORâ„¢ Peptide Enhanced Bone Graft 9/4/2014 11:16:22 AM
CeraPedics, Inc. Closes A $9 Million Term Loan With GE Capital 5/13/2014 7:20:17 AM
GE Believes In CeraPedics, Inc. And Its i-FACTOR Bone Graft 4/21/2014 10:03:31 AM
CeraPedics, Inc. Announces Positive Results From IDE Clinical Trial 3/12/2014 10:26:54 AM
CeraPedics, Inc. To Present Preliminary Outcomes Data From i-FACTORâ„¢ Bone Graft Study At Canaccord Genuity Musculoskeletal Conference 3/5/2014 6:53:01 AM
CeraPedics, Inc. Appoints Glen A. Kashuba as Chief Executive Officer and Jeffrey G. Marx, Ph.D., as President and Chief Operating Officer 5/16/2013 11:07:12 AM
CeraPedics, Inc. Adds New Board Member 3/12/2013 6:25:08 AM
CeraPedics, Inc. Secures $19 Million Series C Financing 12/12/2012 7:07:31 AM
Infuse EU Competitor, CeraPedics, Inc., Working Toward U.S. Clearance for Bone Growth Putty 2/23/2012 8:17:04 AM
CeraPedics, Inc.: Prospective, Randomized, Controlled Trial Demonstrates 98% Fusion Rate at 6-Months and 12-Months with i-FACTOR(TM) Biologic Bone Graft and Superiority versus Autograft in Single- and Multi-Level PLIF Spine Surgery 4/12/2011 9:14:27 AM